G
George Davey Smith
Researcher at University of Bristol
Publications - 2646
Citations - 294406
George Davey Smith is an academic researcher from University of Bristol. The author has contributed to research in topics: Population & Mendelian randomization. The author has an hindex of 224, co-authored 2540 publications receiving 248373 citations. Previous affiliations of George Davey Smith include Keele University & Western Infirmary.
Papers
More filters
Journal ArticleDOI
Pharmacokinetics and analgesic effect of slow-release oral morphine sulphate in volunteers
TL;DR: There was not a significant correlation between analgesia and plasma morphine concentration, and this may result from delay in brain penetration by morphine.
Journal ArticleDOI
Materials analysis with a position-sensitive atom probe
Alfred Cerezo,T.J. Godfrey,Chris R. M. Grovenor,M.G. Hetherington,R. M. Hoyley,J. P. Jakubovics,James Alexander Liddle,George Davey Smith,G.M. Worrall +8 more
TL;DR: The position sensitive atom probe (POSAP) as discussed by the authors has been used to study phase chemistry in a number of metallurgical alloys, including accurate composition determination of 1-2 nm Cu-rich precipitates formed in Fe 1.3% Cu 1.4%Ni aged to peak hardness.
Journal ArticleDOI
The nerve fibre populations of the nerves of the leg in chronic occlusive arterial disease in man.
Journal ArticleDOI
Prenatal Methylmercury Exposure and Genetic Predisposition to Cognitive Deficit at Age 8 Years
Jordi Julvez,George Davey Smith,Jean Golding,Susan M. Ring,Beate St Pourcain,Juan R. González,Philippe Grandjean +6 more
TL;DR: Heterogeneities in several relevant genes suggest possible genetic predisposition to MeHg neurotoxicity in a substantial proportion of the population, and future studies need to address this possibility.
Journal ArticleDOI
Circulating Insulin-Like Growth Factors and IGF-Binding Proteins in PSA-Detected Prostate Cancer: The Large Case–Control Study ProtecT
Mari-Anne Rowlands,Jeffrey M P Holly,David Gunnell,Jenny L Donovan,J. Athene Lane,Freddie C. Hamdy,David E. Neal,Steven E. Oliver,George Davey Smith,Richard M. Martin +9 more
TL;DR: The findings for IGF-I agree with previous results from PSA screening trials, but contrast with positive associations in routinely detected disease, suggesting that reducing levels of circulating IGF- I might not prevent the initiation of prostate cancer but might, nonetheless, prevent its progression.